Clinical and epidemiological features of psoriasis in the Republic of Uzbekistan

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Psoriasis is one of the most common dermatoses. The disease has a negative impact on every aspect of the patient’s life ― social, physical and psychological. Psoriasis is accompanied by a marked deterioration in the quality of life of patients, which often leads to their social maladaptation.

AIMS: This study is aimed at assessing the nature of epidemiological and clinical manifestations of psoriasis in the Republic of Uzbekistan.

MATERIALS AND METHODS: The data of the population register of psoriatic diseases created on the basis of the Republican Skin and Venereological Clinical Hospital the city of Tashkent, the Republican Specialized Scientific and Practical Center of Dermatology and Cosmetology of the Republic of Uzbekistan were studied. A retrospective analysis of case histories for the period 2015–2019 was also carried out at the clinical base of the Department of Dermatovenerology of the Tashkent Medical Academy.

RESULTS: The prevalence of psoriasis among the general population of the Republic of Uzbekistan from 2010 to 2020 during the study period significantly increased, especially in the age group of 15–29 years. Men suffer from psoriasis more often, this disease is characterized by an earlier onset of the disease (age group up to 40 years). The most common clinical form of psoriasis is vulgar psoriasis.

CONCLUSIONS: There is a clear need to improve the quality and increase the amount of data related to the epidemiology of psoriasis in the Republic of Uzbekistan. Diagnostic criteria and reports on morbidity and prevalence should be standardized.

Full Text

Restricted Access

About the authors

Olga Yu. Olisova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN-code: 2500-7989

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

Nigina I. Melikova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: niginamelikova29@gmail.com
ORCID iD: 0000-0003-0404-779X

Graduate Student

Russian Federation, Moscow

Umida A. Tashkenbaeva

Tashkent Medical Academy

Email: umidatashkenbaeva@mail.ru
ORCID iD: 0000-0002-4380-6982
SPIN-code: 7902-5210

MD, Dr. Sci. (Med.), Associate Professor

Uzbekistan, Tashkent

Nikolay V. Torchinskiy

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: torchinsky75@mail.ru
ORCID iD: 0000-0003-3835-0842
SPIN-code: 7797-0908

MD, Cand. Sci. (Med.), Associate Professor

Russian Federation, Moscow

References

  1. Kuchekar AB, Pujari RR, Kuchekar SB, et al. Psoriasis: a comprehensive review. Int J Pharm Life Sci. 2011;2(6):857–877.
  2. Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. 2021;168(6):1303–1310. doi: 10.1111/bjd.12230
  3. Iskandar IY, Parisi R, Griffiths CE, Ashcroft DM; Global Psoriasis Atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184(2):243–258. doi: 10.1111/bjd.19169
  4. Nordqvist C. All about psoriasis [Internet]. Medical news today. Available from: https://www.medicalnewstoday.com/articles/medical-myths-all-about-psoriasis#Summary. Accessed: 15.01.2022.
  5. Murphy G, Reich K. In touch with psoriasis: topical treatments and current guidelines. J Eur Acad Dermatol Venereol. 2011;25(Suppl 4):3–8. doi: 10.1111/j.1468-3083.2011.04059.x
  6. Jacobi A, Mayer A, Augustin M. Keratolytics and emollients and their role in the therapy of psoriasis: a systematic review. Dermatol Ther (Heidelb). 2015;5(1):1–18. doi: 10.1007/s13555-015-0068-3
  7. Pariser D, Schenkel B, Carter C, et al.; Psoriasis Patient Interview Study Group. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis. J Dermatol Treat. 2016;27(1):19–26. doi: 10.3109/09546634.2015.1044492

Supplementary files

Supplementary Files
Action
1. Fig. 1. The prevalence of psoriasis among the total population of the Republic of Uzbekistan in 2010–2020, %.

Download (66KB)
2. Fig. 2. The prevalence of psoriasis among certain age groups in the Republic of Uzbekistan in 2010–2020.

Download (88KB)

Copyright (c) 2022 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 015912 от 28.03.1997 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies